As the Oval Office dominates foreign policy, pro-Israel advocates rethink their Congress-focused playbook

A general view of the U.S. Capitol Building from the National Mall, in Washington, D.C., on Thursday, May 29, 2025.
For decades, Jewish and pro-Israel groups invested significant resources in building bipartisan relationships with key members of Congress to steer legislation, while helping secure foreign aid and blocking unfavorable initiatives concerning the Middle East.
But that long-standing playbook has appeared less effective and relevant in recent years as Congress has increasingly ceded its authority on foreign policy to the executive branch, a trend that has accelerated with President Donald Trump’s return to office. The dynamic is frustrating pro-Israel advocates who had long prioritized Congress as a vehicle of influence, prompting many to reassess the most effective ways to advocate for preferred policies.
That Congress had no formal role in Trump’s recent decisions to unilaterally reach a ceasefire with the Houthis in Yemen and to lift sanctions on Syria, for example, has stoked speculation that legislators could also be sidelined from ratifying a potential nuclear deal with Iran.
There are any number of reasons why Congress has taken a back seat in shaping foreign affairs, experts say, including Trump’s efforts to consolidate power in the executive branch, most recently by gutting the National Security Council. And Trump’s own power in reshaping the ideological direction of his party, preferring diplomacy over military engagement, has made more-hawkish voices within the party more reluctant to speak out against administration policy.
“Congress is increasingly irrelevant except on nominations and taxes,” Elliott Abrams, a senior fellow at the Council on Foreign Relations who served as a special envoy for Iran in the first Trump administration, told Jewish Insider. “It has abandoned its once-central role on tariffs, and plays little role in other foreign affairs issues. That’s a long-term trend and we saw it in previous administrations, but it is worsened by the deadlocks on Capitol Hill, the need to get 60 votes to do almost anything, and by Trump’s centralization of power in the White House.”
Previously, “when there was real power in the departments, congressional oversight meant a lot more,” Abrams added. “If you’re a foreign ambassador in Washington, there’s no one to talk to at the NSC, lots of vacancies at State, and while there are plenty of people to meet with on the Hill, what are they going to do for you? You need to see Trump” Abrams said, or Steve Witkoff, the special envoy to the Middle East leading the negotiations with Iran.
The executive branch, to be sure, has long held significant control over foreign policy but it has expanded considerably in the decades following the 9/11 attacks. Since then, a law passed by Congress to authorize the invasion in Iraq in 2003 has been used — and, critics allege, abused — by successive administrations to initiate military action abroad without first seeking approval from lawmakers who are constitutionally empowered to decide when the country goes to war and oversee defense spending.
Still, Congress has also long shown “disinterest” in exercising its power over foreign policy, said Brian Katulis, a senior fellow at the Middle East Institute. “This was a preexisting condition,” he explained to JI. “By and large, Congress abdicated its oversight role before Trump even came to office,” especially as national security matters have been overshadowed by competing domestic issues such as inflation and immigration, which “resonate more saliently” with voters.
“Trump’s dominance over the Republican Party accounts for much of the acquiescence on the part of his Congress,” observed Stephen Schlesinger, a historian who specializes in international affairs. “But let us not forget that recent Democratic presidents have practically had a free hand, too, in pursuing their own global policies — with little reaction or opposition from their party members.”
Among other examples, Schlesinger cited former President Barack Obama’s nuclear deal with Iran — brokered without consent from Congress — as well as former President Joe Biden’s “total support” for Ukraine in its war against Russia.
Republican deference to Trump, however, has set a new standard for such acquiescence, Schlesinger argued, particularly on talks with Iran. “Given the past obsessive Republican fury against a deal with Iran during Democratic administrations, still none in Trump’s party have objected to a nuclear deal with Tehran under Trump, or, for that matter, his solo decision to lift sanctions on Syria, a country led by a former radical Islamic leader,” Schlesinger noted.
“Certainly the reality of governance in Washington today is that Congress may not be totally irrelevant, but they’re an appendage to the whims and desires of the Trump presidency,” said Norman Ornstein, a senior scholar at the American Enterprise Institute. “There is little if any pushback or oversight of what Trump” and his advisors “involved in foreign policy and diplomacy are doing — and that’s a change.”
The new dynamic has forced pro-Israel groups to adapt to a new political landscape in which their traditional advocacy has been weakened by Congress’ diminished clout and lack of interest in asserting meaningful supervision over Trump’s recent Middle East policy decisions.
“There are very few remedies for this kind of a standoff where the executive branch has arrogated to itself so much power that Congress is essentially marginalized,” said Danielle Pletka, a senior fellow at the American Enterprise Institute who previously worked on the Hill. “When you look at the question of Israel, you have to see it in the context of much broader trends.”
Marshall Wittmann, a spokesperson for AIPAC, argued that both “the administration and Congress play a critical role in strengthening and expanding the U.S.-Israel relationship, and AIPAC works with key leaders in power, on both sides of the aisle and both sides of Pennsylvania Avenue, to build support for the mutually beneficial alliance between America and Israel.”
The absence of congressional influence has come as disagreements have emerged between the Trump administration and the Netanyahu government over ending the war in Gaza and nuclear diplomacy with Iran. Trump’s recent trip to the Middle East — where he met with a range of Arab leaders but did not stop in Israel — was one of the latest indications of deprioritization of America’s closest ally in the region.
Tensions have also surfaced amid ongoing negotiations with Iran. Pro-Israel advocates have voiced concerns that Trump’s negotiating team is nearing an agreement that could simply reinstate the deal brokered by the Obama administration a decade ago — which detractors had criticized as a pathway to a nuclear weapon since it allowed Iran to continue enriching uranium.
The Trump administration has indicated it will not permit Iran to retain domestic nuclear enrichment — even as some officials have sent mixed signals on the matter, contributing to a sense of confusion over the ultimate terms of an agreement. Trump pulled out of the original deal — which was widely opposed by Republicans — during his first administration.
For pro-Israel groups, the risks of clashing with Trump on key issues likely outweigh the benefits, observers contend. “Any organization has to very carefully weigh its equities before publicly taking on the administration,” Daniel Silverberg, a former top foreign policy advisor to Rep. Steny Hoyer (D-MD), told JI.
The pro-Israel lobbying group AIPAC has recognized that it is now operating in a unique landscape, according to Manny Houle, a Democratic pro-Israel strategist who previously served as the group’s progressive outreach director in the Midwest. Before Trump was elected, Howard Kohr, AIPAC’s former president, frequently said the group “was all about Congress,” Houle recalled in a recent interview with JI. “Then, Trump was in office and he said we’re going to be dealing with the White House.”
Marshall Wittmann, a spokesperson for AIPAC, argued that both “the administration and Congress play a critical role in strengthening and expanding the U.S.-Israel relationship, and AIPAC works with key leaders in power, on both sides of the aisle and both sides of Pennsylvania Avenue, to build support for the mutually beneficial alliance between America and Israel.”
“President Trump has a strong pro-Israel and anti-Iran record, but his administration evinced early on a lack of expertise and consistency in its policy toward Iran’s nuclear program,” said Michael Makovsky, president and CEO of the Jewish Institute for National Security of America. “But recently that position has evolved and strengthened due in no small part to feedback it has gotten.”
“We applaud the administration’s strong statements and actions in support of our ally, commend Congress for passing pro-Israel legislation such as the annual appropriation for lifesaving security assistance to Israel, and appreciate President Trump and congressional leaders both making clear last week that Iran must completely dismantle its nuclear program,” Wittmann said in a statement to JI last week.
Even as Congress has failed to take formal action over points of disagreement with Trump’s recent Middle East directives, some pro-Israel activists suggested their outreach to lawmakers on the Iran talks in particular has yielded substantive results in recent weeks.
“President Trump has a strong pro-Israel and anti-Iran record, but his administration evinced early on a lack of expertise and consistency in its policy toward Iran’s nuclear program,” said Michael Makovsky, president and CEO of the Jewish Institute for National Security of America. “But recently that position has evolved and strengthened due in no small part to feedback it has gotten.”
In public and private settings, JINSA and other pro-Israel groups, as well as Israeli officials and congressional Republicans, “have made the case that Trump needs to stick to his initial policy of dismantlement of Iran’s enrichment facilities,” Makovsky said.
“This has contributed to Trump officials pivoting in the past couple weeks to a tougher ‘no enrichment’ stand,” Makovsky told JI last week.
Eric Levine, a top GOP fundraiser and a board member of the Republican Jewish Coalition who recently launched a federal lobbying practice, said “the most important voice Congress will have is if the president makes a deal with Iran. I think that it’s really important that the Senate remains steadfast and safeguards its powers and insists, if there is a deal, it should be counted as a treaty. If he thinks it’s an amazing deal, he should have no trouble passing it.”
Still, it remains to be seen if the toughest voices against Iran in the Senate who have expressed reservations with enrichment limits and other perceived weaknesses of a potential deal will push back against Trump if he lands on an agreement that does not meet their standards. While some Republican lawmakers have spoken out in recent weeks to set expectations for a deal, including Sens. Ted Cruz (R-TX), Tom Cotton (R-AR) and Lindsey Graham (R-SC), observers say they are skeptical that Congress will ultimately seek to flex its authority if an agreement comes forward.
“The ultimate test will be if there’s a vote on Iran,” said former Rep. Steve Israel (D-NY), a pro-Israel Democrat who opposed Obama’s deal in 2015. “As Congress has grown more performative, it has become less deliberative on foreign policy,” he added. “The speaker’s gavel has become a rubber stamp. The result is an abdication by Congress of its delineated responsibilities.”
Eric Levine, a top GOP fundraiser and a board member of the Republican Jewish Coalition who recently launched a federal lobbying practice, said “the most important voice Congress will have is if the president makes a deal with Iran.”
“I think that it’s really important that the Senate remains steadfast and safeguards its powers and insists, if there is a deal, it should be counted as a treaty,” said Levine. “If he thinks it’s an amazing deal, he should have no trouble passing it,” Levine said of Trump’s efforts to reach what he has suggested is an imminent accord.
It is unclear if the White House will seek approval from Congress for a deal, even as lawmakers have recently stressed that an agreement would have no guarantee of surviving in future administrations if not ratified by the legislative branch.
Secretary of State Marco Rubio affirmed during hearings on Capitol Hill last week that U.S. law requires that any deal with Iran be submitted to Congress for review and approval, noting that he had been in Congress when that law, the Iran Nuclear Agreement Review Act, was passed. A White House spokesperson declined to confirm if Trump plans to present a potential deal to Congress when reached by JI on Wednesday, deferring to the president and Witkoff’s remarks from the Oval Office — which did not address the matter.
With Congress increasingly on the sidelines, some pro-Israel groups have turned to alternative forms of advocacy to buttress their lobbying efforts in recent years.
“Advocacy tactics are always changing,” James Thurber, a distinguished professor of government at American University and a leading expert on federal lobbying, told JI. “It is like war where opponents must be flexible, try new tools, assess and adjust. It is essential to be persistently focused on the best strategy, theme and message and to not rely on outdated lobbying tactics.”
“Our world has changed,” said Ann Lewis, a veteran Democratic advisor and a former co-chair of Democratic Majority for Israel, whose formidable political arm has actively engaged in congressional primaries featuring sharp divisions over Israel. “Any definition of advocacy that begins post-election is less effective than it deserves to be.”
Indeed, AIPAC’s foray into campaign politics four years ago, marking a major tactical shift for the organization, was a sign of the changing power dynamics in Washington. The group has since helped to elect a range of congressional allies, while working to unseat some of the fiercest critics of Israel in the House and blocking potential antagonists from getting elected.
“Advocacy tactics are always changing,” James Thurber, a distinguished professor of government at American University and a leading expert on federal lobbying, told JI. “It is like war where opponents must be flexible, try new tools, assess and adjust. It is essential to be persistently focused on the best strategy, theme and message and to not rely on outdated lobbying tactics.”
But as most foreign policy decisions now emanate from the White House, some pro-Israel activists say they remain frustrated by the lack of will from Congress to assert its authority, even as they vow their efforts will continue.
“It is tragic that Congress has so blatantly shirked its responsibility to act as a check and balance on the executive branch,” a senior political operative involved in pro-Israel advocacy recently lamented. “But under no circumstances does that mean we stop fighting for the future of the U.S.-Israel relationship.”